Viking's oral pill reduces up to 12.2% weight but shares slump on higher patient exits – Reuters
- Viking’s oral pill reduces up to 12.2% weight but shares slump on higher patient exits Reuters
- Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill Investor’s Business Daily
- Vital Signs: What to watch for in upcoming oral obesity readouts from Viking, Structure firstwordpharma.com
- Viking Therapeutics: Still On Track (NASDAQ:VKTX) Seeking Alpha
- Viking Therapeutics oral weight loss drug hits mark in mid-stage trial but disappoints investors statnews.com